Lisa Bero, PhD
Research Professor, Medicine-Internal Medicine

Publications

• Toews I, Anglemyer A, Nyirenda JL, Alsaid D, Balduzzi S, Grummich K, Schwingshackl L, Bero L. Healthcare outcomes assessed with observational study designs compared with those assessed in randomized trials: a meta-epidemiological study. Cochrane Database Syst Rev. 2024 Jan 4;1(1):MR000034. PubMed PMID: 38174786
• Grundy Q, Huyer LD, Parker L, Bero L. Branded Care: The Policy Implications of Pharmaceutical Industry-Funded Nursing Care Related to Specialty Medicines. Policy Polit Nurs Pract. 2023 Feb;24(1):67-75. PubMed PMID: 36069065
• Blaxall M, Richardson R, Schoonees A, Metzendorf MI, Durão S, Naude C, Bero L, Farquhar C. Obesity intervention evidence synthesis: Where are the gaps and which should we address first?. Obes Rev. 2023 Dec 27;:e13685. [Epub ahead of print] PubMed PMID: 38151751
• Traeger AC, Bero LA. Corporate Influences on Science and Health-the Case of Spinal Cord Stimulation. JAMA Intern Med. 2023 Dec 18. [Epub ahead of print] PubMed PMID: 38109104
• Page MJ, Sterne JAC, Boutron I, Hróbjartsson A, Kirkham JJ, Li T, Lundh A, Mayo-Wilson E, McKenzie JE, Stewart LA, Sutton AJ, Bero L, Dunn AG, Dwan K, Elbers RG, Kanukula R, Meerpohl JJ, Turner EH, Higgins JPT. ROB-ME: a tool for assessing risk of bias due to missing evidence in systematic reviews with meta-analysis. BMJ. 2023 Nov 20;383:e076754. PubMed PMID: 37984978
• Grundy Q, Held F, Hart D, Baugh CM, Ladd E, Campbell E, Bero L. Characteristics of Advanced Practice Nurses Receiving Top Industry Payments and Their Practice Settings: a Cross-sectional Study. J Gen Intern Med. 2023 Nov 14. [Epub ahead of print] PubMed PMID: 37962732
• Bero L, Lawrence R, Oberste JP, Li T, Leslie L, Rittiphairoj T, Piper C, Wang GS, Brooks-Russell A, Yim TW, Tung G, Samet JM. Health Effects of High-Concentration Cannabis Products: Scoping Review and Evidence Map. Am J Public Health. 2023 Dec;113(12):1332-1342. PubMed PMID: 37939329
• Langford AV, Bero L, Lin CC, Blyth FM, Doctor JN, Holliday S, Jeon YH, Moullin JC, Murnion B, Nielsen S, Penm J, Reeve E, Reid S, Wale J, Osman R, Gnjidic D, Schneider CR. Context matters: using an Evidence to Decision (EtD) framework to develop and encourage uptake of opioid deprescribing guideline recommendations at the point-of-care. J Clin Epidemiol. 2023 Nov 4;165:111204. [Epub ahead of print] PubMed PMID: 37931823
• Wilkinson J, Heal C, Antoniou GA, Flemyng E, Alfirevic Z, Avenell A, Barbour V, Brown NJL, Carlisle J, Clarke M, Dicker P, Dumville J, Grey A, Grohmann S, Gurrin LC, Hayden JA, Heathers J, Hunter KE, Lasserson T, Lam E, Lensen S, Li T, Li W, Loder E, Lundh A, Meyerowitz-Katz G, Mol BW, O' Connell NE, Parker L, Redman BK, Seidler AL, Sheldrick KA, Sydenham E, Torgerson DJ, van Wely M, Wang R, Bero L, Kirkham JJ. Protocol for the development of a tool (INSPECT-SR) to identify problematic randomised controlled trials in systematic reviews of health interventions. medRxiv. 2023 Nov 13. PubMed PMID: 37873409
• Chiu K, Thow AM, Bero L. Understanding the Dynamics of More Restrictive Medicines Policy: A Case Study of Codeine Up-Scheduling in Australia. Int J Health Policy Manag. 2023;12:6872. PubMed PMID: 37579455
• Langford AV, Lin CC, Bero L, Blyth FM, Doctor J, Holliday S, Jeon YH, Moullin J, Murnion B, Nielsen S, Osman R, Penm J, Reeve E, Reid S, Wale J, Schneider CR, Gnjidic D. Clinical practice guideline for deprescribing opioid analgesics: summary of recommendations. Med J Aust. 2023 Jul 17;219(2):80-89. PubMed PMID: 37356051
• Ong YK, Double KL, Bero L, Diong J. Responsible research practices could be more strongly endorsed by Australian university codes of research conduct. Res Integr Peer Rev. 2023 Jun 6;8(1):5. PubMed PMID: 37277861
• Gaber N, Bero L, Woodruff TJ. The Devil they Knew: Chemical Documents Analysis of Industry Influence on PFAS Science. Ann Glob Health. 2023;89(1):37. PubMed PMID: 37273487
• Pokorny AMJ, Bero LA, Fox P, Karikios DJ, McEwin EJ, Moynihan R, Mintzes B. Interactions between Australian cancer physicians and the pharmaceutical industry: a qualitative study. BMJ Open. 2023 May 26;13(5):e065719. PubMed PMID: 37236664
• Parker L, Bero L. Reducing commercial influence over guidelines won't fix poverty but is still worth striving for. BMJ. 2023 Mar 3;380:478. PubMed PMID: 36868572
• Langford AV, Schneider CR, Lin CC, Bero L, Collins JC, Suckling B, Gnjidic D. Patient-targeted interventions for opioid deprescribing: An overview of systematic reviews. Basic Clin Pharmacol Toxicol. 2023 Dec;133(6):623-639. PubMed PMID: 36808693
• Grundy Q, Huyer LD, Parker L, Bero L. Branded Care: The Policy Implications of Pharmaceutical Industry-Funded Nursing Care Related to Specialty Medicines. Policy Polit Nurs Pract. 2023 Feb;24(1):67-75. PubMed PMID: 36069065
• Joosse IR, Tordrup D, Bero L, Mantel-Teeuwisse AK, van den Ham HA. A critical review of methodologies used in pharmaceutical pricing policy analyses. Health Policy. 2023 Aug;134:104576. PubMed PMID: 35317924
• Parker L, Bero L. Managing risk from conflicts of interest in guideline development committees. BMJ. 2022 Dec 6;379:e072252. PubMed PMID: 36593553
• Soskolne CL, Kramer S, Ramos-Bonilla JP, Mandrioli D, Sass J, Gochfeld M, Cranor CF, Advani S, Bero LA. Correction: Toolkit for detecting misused epidemiological methods. Environ Health. 2022 Nov 12;21(1):109. PubMed PMID: 36368967
• Soskolne CL, Bero LA, Kramer S, Gochfeld M, Ramos-Bonilla JP, Sass J, Cranor CF, Advani S, Mandrioli D. Response to Toshihide Tsuda, Yumiko Miyano and Eiji Yamamoto [1]. Environ Health. 2022 Oct 26;21(1):100. PubMed PMID: 36284322
• Parker L, Boughton S, Lawrence R, Bero L. Experts identified warning signs of fraudulent research: a qualitative study to inform a screening tool. J Clin Epidemiol. 2022 Nov;151:1-17. PubMed PMID: 35850426
• Pega F, Momen NC, Bero L, Whaley P. Towards a framework for systematic reviews of the prevalence of exposure to environmental and occupational risk factors. Environ Health. 2022 Jul 6;21(1):64. PubMed PMID: 35794579
• Chiu K, Thow AM, Bero L. The tension between national consistency and jurisdictional professional expansion: The case of pharmacist-administered vaccinations. Res Social Adm Pharm. 2022 Oct;18(10):3782-3791. PubMed PMID: 35537904
• Morrow RL, Mintzes B, Souverein PC, Hallgreen CE, Ahmed B, Roughead EE, De Bruin ML, Kristiansen SB, Lexchin J, Kemp-Casey A, Sketris I, Mangin D, Pearson SA, Puil L, Lopert R, Bero L, Gnjidic D, Sarpatwari A, Dormuth CR. Hydroxyzine Initiation Following Drug Safety Advisories on Cardiac Arrhythmias in the UK and Canada: A Longitudinal Cohort Study. Drug Saf. 2022 Jun;45(6):623-638. PubMed PMID: 35438459
• Chiu K, Thow AM, Bero L. "Never waste a good crisis": Opportunities and constraints from the COVID-19 pandemic on pharmacists' scope of practice. Res Social Adm Pharm. 2022 Sep;18(9):3638-3648. PubMed PMID: 35414485
• Hilton Boon M, Burns J, Craig P, Griebler U, Heise TL, Vittal Katikireddi S, Rehfuess E, Shepperd S, Thomson H, Bero L. Value and Challenges of Using Observational Studies in Systematic Reviews of Public Health Interventions. Am J Public Health. 2022 Apr;112(4):548-552. PubMed PMID: 35319925
• Joosse IR, Tordrup D, Bero L, Mantel-Teeuwisse AK, van den Ham HA. A critical review of methodologies used in pharmaceutical pricing policy analyses. Health Policy. 2022 Mar 13. [Epub ahead of print] PubMed PMID: 35317924
• Pokorny AMJ, Moynihan R, Fox P, Karikios DJ, Bero LA, Mintzes BJ. Australian Cancer Physicians and the Pharmaceutical Industry: A Survey of Attitudes and Interactions. JCO Oncol Pract. 2022 Jul;18(7):e1154-e1163. PubMed PMID: 35316090
• Pega F, Momen NC, Gagliardi D, Bero LA, Boccuni F, Chartres N, Descatha A, Dzhambov AM, Godderis L, Loney T, Mandrioli D, Modenese A, van der Molen HF, Morgan RL, Neupane S, Pachito D, Paulo MS, Prakash KC, Scheepers PTJ, Teixeira L, Tenkate T, Woodruff TJ, Norris SL. Assessing the quality of evidence in studies estimating prevalence of exposure to occupational risk factors: The QoE-SPEO approach applied in the systematic reviews from the WHO/ILO Joint Estimates of the Work-related burden of disease and Injury. Environ Int. 2022 Mar;161:107136. PubMed PMID: 35182944
• Baram L, Dai Z, McDonald S, Bero LA. Disclosure of funding sources and conflicts of interest in evidence underpinning vitamin D and calcium recommendations in bone health guidelines. Public Health Nutr. 2022 Jan 24;:1-8. [Epub ahead of print] PubMed PMID: 35067274
• Morrow RL, Mintzes B, Souverein PC, De Bruin ML, Roughead EE, Lexchin J, Kemp-Casey A, Puil L, Sketris I, Mangin D, Hallgreen CE, Pearson SA, Lopert R, Bero L, Ofori-Asenso R, Gnjidic D, Sarpatwari A, Perry LT, Dormuth CR. Influence of drug safety advisories on drug utilisation: an international interrupted time series and meta-analysis. BMJ Qual Saf. 2022 Mar;31(3):179-190. PubMed PMID: 35058332
• Korevaar E, Karahalios A, Turner SL, Forbes AB, Taljaard M, Cheng AC, Grimshaw JM, Bero L, McKenzie JE. Methodological systematic review recommends improvements to conduct and reporting when meta-analyzing interrupted time series studies. J Clin Epidemiol. 2022 May;145:55-69. PubMed PMID: 35045318
• Bero L. Stamp out fake clinical data by working together. Nature. 2022 Jan;601(7892):167. PubMed PMID: 35017708
• Kanukula R, McKenzie JE, Bero L, Dai Z, McDonald S, Kroeger CM, Korevaar E, Page MJ. Methods used to select results to include in meta-analyses of nutrition research: A meta-research study. J Clin Epidemiol. 2022 Feb;142:171-183. PubMed PMID: 34780979
• Pokorny AMJ, Fabbri A, Bero LA, Moynihan R, Mintzes BJ. Interactions with the pharmaceutical industry and the practice, knowledge and beliefs of medical oncologists and clinical haematologists: a systematic review. Br J Cancer. 2022 Jan;126(1):144-161. PubMed PMID: 34599297
• Fabbri A, Nejstgaard CH, Grundy Q, Bero L, Dunn AG, Mohammad A, Mintzes B. Association Between Conflicts of Interest and Authors' Positions on Harms of Varenicline: a Cross-Sectional Analysis. J Gen Intern Med. 2022 Feb;37(2):290-297. PubMed PMID: 34037923
• Bero L. Industry influence on research: A cycle of bias in Commercial Determinants of Health, Ed Sandro Galea. Oxford University Press. 2022
• Industry influence on research: A cycle of bias in Commercial Determinants of Health, Ed Sandro Galea. Oxford University Press. 2023
• Wang Z, Bero L, Grundy Q. Understanding professional stakeholders' active resistance to guideline implementation: The case of Canadian breast screening guidelines. Soc Sci Med. 2021 Jan;269:113586. PubMed PMID: 33333377
• Pokorny AMJ, Bero LA, Moynihan R, Mintzes BJ. Industry payments to Australian medical oncologists and clinical haematologists: a cross-sectional analysis of publicly available disclosures. Intern Med J. 2021 Nov;51(11):1816-1824. PubMed PMID: 32744396
• Parker L, Bennett A, Mintzes B, Grundy Q, Fabbri A, Karanges EA, Bero L. "There are ways … drug companies will get into DTC decisions": How Australian drug and therapeutics committees address pharmaceutical industry influence. Br J Clin Pharmacol. 2021 May;87(5):2341-2353. PubMed PMID: 33129226
• Langford AV, Gnjidic D, Lin CC, Bero L, Penm J, Blyth FM, Schneider CR. Challenges of opioid deprescribing and factors to be considered in the development of opioid deprescribing guidelines: a qualitative analysis. BMJ Qual Saf. 2021 Feb;30(2):133-140. PubMed PMID: 32220937
• Turner SL, Karahalios A, Forbes AB, Taljaard M, Grimshaw JM, Korevaar E, Cheng AC, Bero L, McKenzie JE. Creating effective interrupted time series graphs: Review and recommendations. Res Synth Methods. 2021 Jan;12(1):106-117. PubMed PMID: 32657532
• Kanukula R, McKenzie JE, Bero L, Dai Z, McDonald S, Kroeger CM, Korevaar E, Page MJ. Methods used to select results to include in meta-analyses of nutrition research: A meta-research study. J Clin Epidemiol. 2021 Nov 12;142:171-183. [Epub ahead of print] PubMed PMID: 34780979
• Mintzes B, Bhasale A, Torka M, Lopert R, Pearson SA, Lexchin J, Bero L. A sorry tale of unnecessary secrecy about medicine safety. Intern Med J. 2021 Oct;51(10):1765-1766. PubMed PMID: 34664366
• Helfer B, Leonardi-Bee J, Mundell A, Parr C, Ierodiakonou D, Garcia-Larsen V, Kroeger CM, Dai Z, Man A, Jobson J, Dewji F, Kunc M, Bero L, Boyle RJ. Conduct and reporting of formula milk trials: systematic review. BMJ. 2021 Oct 13;375:n2202. PubMed PMID: 34645600
• Neumann I, Schünemann HJ, Bero L, Cooke G, Magrini N, Moja L. Global access to affordable direct oral anticoagulants. Bull World Health Organ. 2021 Sep 1;99(9):653-660. PubMed PMID: 34475602
• Karanges EA, Nangla C, Parker L, Fabbri A, Farquhar C, Bero L. Pharmaceutical industry payments and assisted reproduction in Australia: a retrospective observational study. BMJ Open. 2021 Aug 31;11(9):e049710. PubMed PMID: 34465582
• Soskolne CL, Kramer S, Ramos-Bonilla JP, Mandrioli D, Sass J, Gochfeld M, Cranor CF, Advani S, Bero LA. Toolkit for detecting misused epidemiological methods. Environ Health. 2021 Aug 19;20(1):90. PubMed PMID: 34412643
• Dai Z, McKenzie JE, McDonald S, Baram L, Page MJ, Allman-Farinelli M, Raubenheimer D, Bero LA. Assessment of the Methods Used to Develop Vitamin D and Calcium Recommendations-A Systematic Review of Bone Health Guidelines. Nutrients. 2021 Jul 15;13(7). PubMed PMID: 34371932
• Diong J, Kroeger CM, Reynolds KJ, Barnett A, Bero LA. Strengthening the incentives for responsible research practices in Australian health and medical research funding. Res Integr Peer Rev. 2021 Aug 2;6(1):11. PubMed PMID: 34340719
• Bero L, Lawrence R, Leslie L, Chiu K, McDonald S, Page MJ, Grundy Q, Parker L, Boughton S, Kirkham JJ, Featherstone R. Cross-sectional study of preprints and final journal publications from COVID-19 studies: discrepancies in results reporting and spin in interpretation. BMJ Open. 2021 Jul 16;11(7):e051821. PubMed PMID: 34272226
• Bero LA, Parker L. Risky business? Pharmaceutical industry sponsorship of health consumer groups. Aust Prescr. 2021 Jun;44(3):74-76. PubMed PMID: 34211242
• Boughton SL, Wilkinson J, Bero L. When beauty is but skin deep: dealing with problematic studies in systematic reviews. Cochrane Database Syst Rev. 2021 Jun 3;6:ED000152. PubMed PMID: 34081324
• Verbeek J, Hoving J, Boschman J, Chong LY, Livingstone-Banks J, Bero L. Systematic Reviews Should Consider Effects From Both the Population and the Individual Perspective. Am J Public Health. 2021 May;111(5):820-825. PubMed PMID: 33826374
• Langford AV, Gnjidic D, Lin CC, Bero L, Blyth F, Penm J, Schneider CR. "The lesser of two evils": a framework analysis of consumers' perspectives on opioid deprescribing and the development of opioid deprescribing guidelines. Pain. 2021 Nov 1;162(11):2686-2692. PubMed PMID: 33769364
• Lexchin J, Bero LA, Davis C, Gagnon MA. Achieving greater independence from commercial influence in research. BMJ. 2021 Mar 9;372:n370. PubMed PMID: 33687982
• Parker L, Grundy Q, Fabbri A, Mintzes B, Bero L. 'Lines in the sand': an Australian qualitative study of patient group practices to promote independence from pharmaceutical industry funders. BMJ Open. 2021 Feb 9;11(2):e045140. PubMed PMID: 33563626
• Wang Z, Bero L, Grundy Q. Understanding professional stakeholders' active resistance to guideline implementation: The case of Canadian breast screening guidelines. Soc Sci Med. 2021 Jan;269:113586. PubMed PMID: 33333377
• Turner SL, Karahalios A, Forbes AB, Taljaard M, Grimshaw JM, Korevaar E, Cheng AC, Bero L, McKenzie JE. Creating effective interrupted time series graphs: Review and recommendations. Res Synth Methods. 2021 Jan;12(1):106-117. PubMed PMID: 32657532
• Korevaar E, Karahalios A, Forbes AB, Turner SL, McDonald S, Taljaard M, Grimshaw JM, Cheng AC, Bero L, McKenzie JE. Methods used to meta-analyse results from interrupted time series studies: A methodological systematic review protocol. F1000Res. 2020;9:110. PubMed PMID: 33163155
• Nejstgaard CH, Bero L, Hróbjartsson A, Jørgensen AW, Jørgensen KJ, Le M, Lundh A. Association between conflicts of interest and favourable recommendations in clinical guidelines, advisory committee reports, opinion pieces, and narrative reviews: systematic review. BMJ. 2020 Dec 9;371:m4234. PubMed PMID: 33298430
• Nejstgaard CH, Bero L, Hróbjartsson A, Jørgensen AW, Jørgensen KJ, Le M, Lundh A. Conflicts of interest in clinical guidelines, advisory committee reports, opinion pieces, and narrative reviews: associations with recommendations. Cochrane Database Syst Rev. 2020 Dec 8;12:MR000040. PubMed PMID: 33289919
• Chartres N, Fabbri A, McDonald S, Diong J, McKenzie JE, Bero L. Association of food industry ties with findings of studies examining the effect of dairy food intake on cardiovascular disease and mortality: systematic review and meta-analysis. BMJ Open. 2020 Dec 4;10(12):e039036. PubMed PMID: 33277278
• Wang Z, Grundy Q, Parker L, Bero L. Variations in processes for guideline adaptation: a qualitative study of World Health Organization staff experiences in implementing guidelines. BMC Public Health. 2020 Nov 23;20(1):1758. PubMed PMID: 33228608
• Soares-Weiser K, Lasserson T, Jorgensen KJ, Woloshin S, Bero L, Brown MD, Fischhoff B. Policy makers must act on incomplete evidence in responding to COVID-19. Cochrane Database Syst Rev. 2020 Nov 20;11:ED000149. PubMed PMID: 33215686
• Parker L, Bennett A, Mintzes B, Grundy Q, Fabbri A, Karanges EA, Bero L. "There are ways … drug companies will get into DTC decisions": How Australian drug and therapeutics committees address pharmaceutical industry influence. Br J Clin Pharmacol. 2020 Oct 31. [Epub ahead of print] PubMed PMID: 33129226
• Bero LA. Improving the Quality of Systematic Reviews in Public Health: Introduction to the Series. Am J Public Health. 2020 Nov;110(11):1601-1602. PubMed PMID: 33026865
• Chiu K, McDonald S, Legg T, Karanges EA, Bero L. Policies affecting the supply and access of opioid analgesics: a scoping review protocol. JBI Evid Synth. 2020 May;18(5):1124-1134. PubMed PMID: 32813367
• Pokorny AMJ, Bero LA, Moynihan R, Mintzes BJ. Industry payments to Australian medical oncologists and clinical haematologists: a cross-sectional analysis of publicly-available disclosures. Intern Med J. 2020 Aug 3. [Epub ahead of print] PubMed PMID: 32744396
• Mialon M, Vandevijvere S, Carriedo-Lutzenkirchen A, Bero L, Gomes F, Petticrew M, McKee M, Stuckler D, Sacks G. Mechanisms for addressing and managing the influence of corporations on public health policy, research and practice: a scoping review. BMJ Open. 2020 Jul 19;10(7):e034082. PubMed PMID: 32690498
• Chartres N, Grundy Q, Parker LM, Bero LA. "It's Not Smooth Sailing": Bridging the Gap Between Methods and Content Expertise in Public Health Guideline Development. Int J Health Policy Manag. 2020 Aug 1;9(8):335-343. PubMed PMID: 32610737
• Moynihan R, Macdonald H, Bero L, Godlee F. Commercial influence and covid-19. BMJ. 2020 Jun 24;369:m2456. PubMed PMID: 32580930
• Dai Z, Kroeger CM, Lawrence M, Scrinis G, Bero L. Comparison of methodological quality between the 2007 and 2019 Canadian dietary guidelines. Public Health Nutr. 2020 Nov;23(16):2879-2885. PubMed PMID: 32552917
• Taylor KW, Wang Z, Walker VR, Rooney AA, Bero LA. Using interactive data visualization to facilitate user selection and comparison of risk of bias tools for observational studies of exposures. Environ Int. 2020 Sep;142:105806. PubMed PMID: 32505018
• Moynihan R, Albarqouni L, Nangla C, Dunn AG, Lexchin J, Bero L. Financial ties between leaders of influential US professional medical associations and industry: cross sectional study. BMJ. 2020 May 27;369:m1505. PubMed PMID: 32461201
• Bero LA. Producing Independent, Systematic Review Evidence: Cochrane's Response to COVID-19. Am J Public Health. 2020 Jul;110(7):952-953. PubMed PMID: 32407142
• Turner K, Carboni-Jiménez A, Benea C, Elder K, Levis B, Boruff J, Roseman M, Bero L, Lexchin J, Turner EH, Benedetti A, Thombs BD. Reporting of drug trial funding sources and author financial conflicts of interest in Cochrane and non-Cochrane meta-analyses: a cross-sectional study. BMJ Open. 2020 May 11;10(5):e035633. PubMed PMID: 32398334
• Moynihan R, Fabbri A, Parker L, Bero L. Mixed methods evaluation of workshops for citizen health advocates about financial conflicts of interests in healthcare. BMJ Open. 2020 May 10;10(5):e034195. PubMed PMID: 32393611
• Benea C, Turner KA, Roseman M, Bero LA, Lexchin J, Turner EH, Thombs BD. Reporting of financial conflicts of interest in meta-analyses of drug trials published in high-impact medical journals: comparison of results from 2017 to 2018 and 2009. Syst Rev. 2020 Apr 8;9(1):77. PubMed PMID: 32268911
• Ding D, Nguyen B, Gebel K, Bauman A, Bero L. Duplicate and salami publication: a prevalence study of journal policies. Int J Epidemiol. 2020 Feb 1;49(1):281-288. PubMed PMID: 32244256
• Grundy Q, Mazzarello S, Bero L. A comparison of policy provisions for managing "financial" and "non-financial" interests across health-related research organizations: A qualitative content analysis. Account Res. 2020 May;27(4):212-237. PubMed PMID: 32233796
• Langford AV, Gnjidic D, Lin CC, Bero L, Penm J, Blyth FM, Schneider CR. Challenges of opioid deprescribing and factors to be considered in the development of opioid deprescribing guidelines: a qualitative analysis. BMJ Qual Saf. 2020 Mar 27. [Epub ahead of print] PubMed PMID: 32220937
• Grundy Q, Dunn AG, Bero L. Improving researchers' conflict of interest declarations. BMJ. 2020 Mar 11;368:m422. PubMed PMID: 32161006
• Karanges EA, Ting N, Parker L, Fabbri A, Bero L. Pharmaceutical industry payments to leaders of professional medical associations in Australia: Focus on cardiovascular disease and diabetes. Aust J Gen Pract. 2020 Mar;49(3):151-154. PubMed PMID: 32113215
• Turner SL, Karahalios A, Forbes AB, Taljaard M, Grimshaw JM, Cheng AC, Bero L, McKenzie JE. Design characteristics and statistical methods used in interrupted time series studies evaluating public health interventions: a review. J Clin Epidemiol. 2020 Jun;122:1-11. PubMed PMID: 32109503
• Grundy Q, Mayes C, Holloway K, Mazzarello S, Thombs BD, Bero L. Conflict of interest as ethical shorthand: understanding the range and nature of "non-financial conflict of interest" in biomedicine. J Clin Epidemiol. 2020 Apr;120:1-7. PubMed PMID: 31866470
• Pega F, Norris SL, Backes C, Bero LA, Descatha A, Gagliardi D, Godderis L, Loney T, Modenese A, Morgan RL, Pachito D, Paulo MBS, Scheepers PTJ, Schlünssen V, Sgargi D, Silbergeld EK, Sørensen K, Sutton P, Tenkate T, Torreão Corrêa da Silva D, Ujita Y, van Deventer E, Woodruff TJ, Mandrioli D. RoB-SPEO: A tool for assessing risk of bias in studies estimating the prevalence of exposure to occupational risk factors from the WHO/ILO Joint Estimates of the Work-related Burden of Disease and Injury. Environ Int. 2020 Feb;135:105039. PubMed PMID: 31864023
• Samet JM, Chiu WA, Cogliano V, Jinot J, Kriebel D, Lunn RM, Beland FA, Bero L, Browne P, Fritschi L, Kanno J, Lachenmeier DW, Lan Q, Lasfargues G, Le Curieux F, Peters S, Shubat P, Sone H, White MC, Williamson J, Yakubovskaya M, Siemiatycki J, White PA, Guyton KZ, Schubauer-Berigan MK, Hall AL, Grosse Y, Bouvard V, Benbrahim-Tallaa L, El Ghissassi F, Lauby-Secretan B, Armstrong B, Saracci R, Zavadil J, Straif K, Wild CP. The IARC Monographs: Updated Procedures for Modern and Transparent Evidence Synthesis in Cancer Hazard Identification. J Natl Cancer Inst. 2020 Jan 1;112(1):30-37. PubMed PMID: 31498409
• Trevena H, Reeve B, Bero L, Thow AM. Private food safety standards in the global food supply chain: a scoping review protocol. JBI Evid Synth. 2020 Jan;18(1):97-107. PubMed PMID: 31389853